Dr. Brock O’Neil and PGY 4 Matt Armstrong published a paper “18F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment”, that was featured in Renal and Urology News and the AUA Daily Scope.